Page last updated: 2024-09-25

4-methylumbelliferylcellobioside

Description

4-methylumbelliferylcellobioside: substrate for cellobiohydrolase I [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID126287
CHEBI ID177566
MeSH IDM0187280

Synonyms (24)

Synonym
7-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-methylchromen-2-one
mfcd00063279
CHEBI:177566
4-methylumbelliferyl beta-d-cellobioside, glucanase substrate
4-methylumbelliferyl-beta-d-cellobioside
72626-61-0
4-methylumbelliferyl-beta-d-cellobiopyranoside
4-methylumbelliferyl |a-d-cellobioside
4-methylumbeiliferyl-beta-d-cellobioside
4-methylumbelliferyl beta-d-cellobioside
AKOS016015742
7-((4-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-4-methyl-2h-1-benzopyran-2-one
4-methylumbelliferylcellobioside
2h-1-benzopyran-2-one, 7-((4-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-4-methyl-
einecs 276-744-7
AKOS015899869
AS-63224
4-methylumbelliferyl beta-cellobioside
4-methyl-2-oxo-2h-chromen-7-yl 4-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
D97721
DTXSID401294953
4-methylumbelliferyl beta -d-cellobioside
7-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-methyl-2h-chromen-2-one
4-methylumbelliferyl bate-d-cellobioside

Drug Classes (2)

ClassDescription
coumarins
glycosideA glycosyl compound resulting from the attachment of a glycosyl group to a non-acyl group RO-, RS-, RSe-, etc. The bond between the glycosyl group and the non-acyl group is called a glycosidic bond. By extension, the terms N-glycosides and C-glycosides are used as class names for glycosylamines and for compounds having a glycosyl group attached to a hydrocarbyl group respectively. These terms are misnomers and should not be used. The preferred terms are glycosylamines and C-glycosyl compounds, respectively.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]